All articles

CGM Sensors: How Real-Time Glucose Monitoring Is Changing Diabetes Treatment

CGM Sensors: How Real-Time Glucose Monitoring Is Changing Diabetes Treatment

From Fingersticks to Continuous Monitoring

For decades, glucose self-monitoring meant fingerstick glucometers — devices that provide a single glucose value at one moment in time. It is like assessing the weather from a single daily snapshot. Continuous glucose monitoring (CGM) systems changed the paradigm: they measure interstitial fluid glucose every 1-5 minutes, generating up to 288 data points per day.

The CGM market reached $8.2 billion in 2024 and is projected to exceed $15 billion by 2028. The technology has expanded well beyond type 1 diabetes — CGM is now used by patients with type 2 diabetes, prediabetes, and even metabolically healthy individuals seeking optimization.

How CGM Sensors Work

A CGM sensor is a miniature electrochemical biosensor inserted subcutaneously (typically on the back of the upper arm or abdomen). A thin filament electrode (5-7 mm long, <0.4 mm diameter) is coated with glucose oxidase enzyme, which catalyzes glucose oxidation in interstitial fluid. The generated electrical current is proportional to glucose concentration.

Data is transmitted via Bluetooth or NFC to a smartphone or reader. Important: CGM measures interstitial fluid glucose, not blood glucose. There is a physiological 5-15 minute lag between blood and interstitial glucose changes.

Current CGM Systems (2025-2026)

### FreeStyle Libre 3 (Abbott)

  • Size: 21.2 mm (smallest CGM sensor globally) - Wear time: 14 days - Readings: every minute - Transmission: Bluetooth Low Energy (continuous) - Accuracy: MARD 7.9% (among the best) - Calibration: factory-calibrated (none required) - Alerts: customizable hypo/hyperglycemia notifications - Water resistance: IP27 (submersion to 1 m for 30 minutes)
  • ### Dexcom G7

  • Size: 28 mm (60% smaller than G6) - Wear time: 10 days + 12-hour grace period - Readings: every 5 minutes - Transmission: Bluetooth - Accuracy: MARD 8.2% (adults) - Calibration: not required - Integration: compatible with insulin pumps (Omnipod 5, Tandem Mobi) - Unique feature: trend arrows showing rate of change
  • ### Dexcom Stelo (2025)

  • First CGM approved by FDA for people not on insulin - Target audience: type 2 diabetes without insulin, prediabetes - Wear time: 15 days - Available OTC (over-the-counter) in the USA - Simplified interface without hypoglycemia alerts
  • ### SiBio KS1 (Ketones)

  • First continuous ketone monitor in the world - Wear time: 14 days - Measures beta-hydroxybutyrate (BHB) in interstitial fluid - Ideal for monitoring ketosis (ketogenic diet, intermittent fasting) - Combined with CGM provides complete metabolic picture
  • Key CGM Metrics

    ### Time in Range (TIR)

    International consensus targets (Battelino et al., Diabetes Care, 2019): - Target range: 70-180 mg/dL (3.9-10.0 mmol/L) - Optimal TIR: >70% (>16 hours 48 minutes per day) - Hypoglycemia (<70 mg/dL): <4% (<58 minutes) - Severe hypoglycemia (<54 mg/dL): <1% - Hyperglycemia (>180 mg/dL): <25% - Severe hyperglycemia (>250 mg/dL): <5%

    Each 5% increase in TIR is associated with approximately 0.5% reduction in HbA1c (Beck et al., Annals of Internal Medicine, 2019). TIR >70% correlates with HbA1c <7%.

    ### Glycemic Variability

    Coefficient of Variation (CV) — key glycemic stability indicator. CV <36% is considered stable; CV >36% is unstable with increased hypoglycemia risk. Monnier et al. (Diabetes Care, 2017) demonstrated that glycemic variability is an independent risk factor for cardiovascular complications.

    Ambulatory Glucose Profile (AGP) — a standardized report combining 14 days of data into one visual picture: median, 25th/75th percentiles, 5th/95th percentiles.

    Practical Applications

    ### Type 1 Diabetes

    CGM + insulin pump = hybrid closed-loop system. The algorithm automatically adjusts basal insulin based on CGM data. NEJM (2022): such systems increased TIR from 51% to 68% in adolescents with T1D.

    ### Type 2 Diabetes

    FLASH-UK study (Lancet, 2022): FreeStyle Libre in T2D patients on insulin reduced HbA1c by 0.5% and decreased time in hypoglycemia by 43%. CGM helps patients see the impact of specific foods, physical activity, and stress on glucose.

    ### Prediabetes and Metabolic Health

    A two-week CGM trial enables: identifying individual glycemic responses to foods, detecting hidden glucose spikes (reactive hypoglycemia, nocturnal elevations), assessing the impact of sleep and stress, and motivating behavioral change through visual biofeedback.

    CGM Limitations

  • Lag time: 5-15 minute delay — critical during rapid changes - Extreme range accuracy: lower at <70 and >300 mg/dL - First 24 hours: less accurate readings (stabilization period) - Compression lows: false hypoglycemia from pressure on sensor during sleep - Interference: acetaminophen may elevate readings on older models - Cost: $75-300/month without insurance
  • How to Start Using CGM

    1. Define your goal: diabetes management, metabolic optimization, ketosis monitoring 2. Choose a system: FreeStyle Libre 3 (best value), Dexcom G7 (best pump integration) 3. Set duration: minimum 14 days for a complete picture 4. Keep a food diary: correlate meals with glycemic responses 5. Physician interpretation: present the AGP report to your endocrinologist

    Frequently Asked Questions

    Do I need CGM for type 2 diabetes without insulin? Even a short course (2-4 weeks) provides valuable insights. Dexcom Stelo was FDA-approved specifically for this group. Visual biofeedback motivates behavioral change.

    Does CGM replace a glucometer? For most decisions, yes. However, when accuracy is in doubt (compression, rapid change), a confirmatory fingerstick is recommended.

    Can a healthy person benefit from CGM? Yes, for metabolic optimization. It reveals individual food responses and hidden insulin resistance. A 2-4 week course is informative.

    Is CGM insertion painful? Most users describe a light click sensation. The filament electrode is so thin that it is typically not felt after insertion.

    *This article is for educational purposes only. CGM system selection and data interpretation should be done in consultation with your healthcare provider.*

    Share
    Follow on TelegramGet new articles, research updates and practical health tips
    Читать на русскомЧитати українською

    This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician before making health decisions. Full disclaimer

    Ready to Take Action?

    85% of patients achieve remission in 3-6 months. Book a consultation and discover your potential.

    Book consultationAsk a question